The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
June 18th 2025
Knowledge gaps, financial burdens, and skepticism hinder Hispanic men’s participation in the National Diabetes Prevention Program, a study finds.
Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.
Cutting Sugary Drink Sales by 20% Through Education, Not a Tax
CMS Sets Eligibility Rules for Medicare Diabetes Prevention Program
Kristen McGovern Discusses the Reluctance to Reimburse Telemedicine